MÜRŞİT DİNCER, Aziz Serkan SENGER, Orhan UZUN, Ayşegül YEŞİLGÖZ SELEK, MUSTAFA DUMAN

Malign Mesothelioma Presenting with Features of Sigmoid Colon Obstruction and Perforation

Malign mesothelioma of the peritoneum is rare and its diagnosis is difficult. Most patients affected by this tumor have abdominal pain, ascites and abdominal mass. Diagnosis is commonly made by laparoscopy or laparotomy. Special immunohistochemical staining supports the diagnosis. Surgery is the most effective treatment. In this report, we describe a malignant mesothelioma presenting with features of colon tumor perforation. Literature is reviewed, there is no case report with malignant mesothelioma presenting with features of colon tumor perforation.

Sigmoid Kolonda Obstruksiyon ve Perforasyona Neden Olan Malign Mezotelyoma

Malign mezotelyoma peritoneal tutulumu nadir olan tanısı güç konulan bir hastalıktır. Çoğunlukla hastalarda karın ağrısı, asit, karın içi kitle ile bulgu verir. Tanı daha çok laparoskopi veya laparotomi sırasında konulur. Patolojik incelemede özel immünohistokimyasal boyalar tanıyı destekler. Cerrahi en etkili tedavi yöntemidir. Burada intraabdominal abse kliniği ile ortaya çıkan sigmoid kolonda obstruksiyon ve perforasyona yol açan malign mezotelyoma vakasını sunduk. Literatür gözden geçirildiğinde kolon perforasyonuna neden olan malign mezotelyoma olgusuna rastlanmadı.

PDF

___

1. Khalil MW, Campbell AP, Cowen ME. Epithelioid malignant mesothelioma presenting with features of esophageal tumor. Asian Cardiovasc Thorac Ann 2011 Jun; 19: 260-261.

2. Gutzeita A, Reischauera C, Herganc K, Kosb S, Roosa JE. Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma. Case Rep Oncol 2013; 6: 236–241.

Peritoneal Mesothelioma: A rare Case Report. Annals of Nuclear Medicine and Molecular İmaging 2011; 24: 138-140.

4. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing Surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21: 4560-4567.